Venture Life Group plc (AIM: VLG)

Market Cap	50.69M
Revenue (ttm)	51.41M
Net Income (ttm)	742.00K
Shares Out	127.05M
EPS (ttm)	0.01
PE Ratio	72.94
Forward PE	7.39
Dividend	n/a
Ex-Dividend Date	n/a

Volume	170,480
Open	40.10
Previous Close	41.00
Day's Range	39.00 - 41.00
52-Week Range	29.50 - 51.29
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 24, 2024

About Venture Life Group

Venture Life Group plc develops and commercializes healthcare products in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally. The company offers oral healthcare products, including mouthwash, toothpaste, breath freshening capsules, and dental accessories under UltraDEX and Dentyl Dual Action brands; and proctology products, such as Procto-eze Plus range for treating the discomfort caused by haemorrhoids. It also provides dermatology products comprising Myco Clear, a fungal nail cleanser ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2005
• Employees: 165
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: VLG

Financial Performance

In 2023, Venture Life Group's revenue was 51.41 million, an increase of 16.89% compared to the previous year's 43.98 million. Earnings were 921,000, an increase of 77.12%.